Showing results (1441-1450 of 3,615) with videos related to
Sort By:
Pageof 362
Journal of Viral Hepatitis|December 6, 2013
Valuable antiviral therapeutic options for the treatment of chronic hepatitis C patients with thrombocytopeniaE Ogawa, N Furusyo, M Murata, et al.Journal of Viral Hepatitis|December 6, 2013
Maternal immunization promotes the immune response of neonates towards hepatitis B vaccineW Zhang, Z Guo, L Zhang, et al.Journal of Viral Hepatitis|December 6, 2013
A paucity of liver disease in Canadian Inuit with chronic hepatitis B virus, subgenotype B6 infectionG Y Minuk, S Macrury, J Uhanova, et al.Journal of Viral Hepatitis|October 31, 2013
The new paradigm of hepatitis C therapy: integration of oral therapies into best practicesN H Afdhal, S Zeuzem, R T Schooley, et al.Journal of Viral Hepatitis|October 31, 2013
Who is more likely to respond to dual treatment with pegylated-interferon and ribavirin for chronic hepatitis C? A gender-oriented analysisV Di Marco, L Covolo, V Calvaruso, et al.Journal of Viral Hepatitis|December 17, 2013
Impact of ribavirin priming on viral kinetics and treatment response in chronic hepatitis C genotype 1 infectionU Mihm, M-W Welker, G Teuber, et al.Journal of Viral Hepatitis|December 17, 2013
Cross-sectional and dynamic change of serum metabolite profiling for Hepatitis B-related acute-on-chronic liver failure by UPLC/MSC Y Nie, T Han, L Zhang, et al.Journal of Viral Hepatitis|December 17, 2013
Predictors associated with treatment initiation and switch in a real-world chronic hepatitis B population from five European countriesH Leblebicioglu, V Arama, X Causse, et al.Journal of Viral Hepatitis|May 11, 2012
Renal function during treatment with adefovir plus peginterferon alfa-2a vs either drug alone in hepatitis B/D co-infectionI Mederacke, C Yurdaydin, A Großhennig, et al.Journal of Viral Hepatitis|May 11, 2012
Increased Th17 cells contribute to disease progression in patients with HBV-associated liver cirrhosisH Q Sun, J Y Zhang, H Zhang, et al.Pageof 362